Science news articles about 'leukemia group'Molecular change may reveal risk of leukemia relapse
... effective therapy, and lead to new targeted therapies for leukemia,” says study leader Dr. Clara D. ... through a clinical trial sponsored by the Cancer and Leukemia Group B (CALGB), a national clinical ... Gene mutation improves leukemia drug's effect
... to high doses of a particular anticancer drug. The findings, from a Cancer and Leukemia Group B clinical cooperative group study led by Dr. Clara D. Bloomfield, an internationally known AML ... Microenvironment a main driver of aggressive multi-lineage leukemia disease type
... particularly aggressive group of blood cancers known as mixed lineage leukemias (MLL) and how the disease ... early biological processes where human leukemia stem cells can be altered to form a particular ... Not the protein, but its location in the cell, determines the onset of leukemia
... white blood cells in our body combat foreign intruders, such as viruses and bacteria. However, in leukemia, the formation of white blood cells is disturbed: the cells that should develop into white ... Lab study shows methadone breaks resistance in untreatable forms of leukemia
... after methadone treatment.
To their surprise, they found that methadone also effectively killed leukemia that was resistant to multiple chemotherapies and to radiation. Probing the mechanism of ... Why Gene Therapy Caused Leukemia In Some 'Boy In The Bubble Syndrome' Patients
... disorder in which the patient lacks most types of immune cell. Almost 10 years ago, two independent groups used gene therapy to treat a few infants with the most common form of SCID, SCID-X1, which is ... Mouse model highlights histone methylation as distinguishing feature for leukemia subtypes
... a new mouse model has led to the identification of a potential therapeutic target for a type of leukemia commonly associated with an unfavorable prognosis. The study, published by Cell Press in the ... UCSD researchers identify potential new drug target for chronic leukemia
... discovered what could be a novel drug target for an often difficult-to-treat form of leukemia. The investigators have identified a unique "signature" or pattern of a specific family of enzymes in ... Interactive gene 'networks' may predict if leukemia is aggressive or slow-growing
... Moores UCSD Cancer Center have evidence that groups, or networks, of interactive genes may be more reliable in determining the likelihood that a form of leukemia is fast-moving or slow-growing. One ... Interactive Gene 'Networks' May Predict If Leukemia Is Aggressive Or Slow-growing
... genes or proteins, researchers have evidence that groups, or networks, of interactive genes may be more reliable in determining the likelihood that a form of leukemia is fast-moving or slow-growing.Stem cells and leukemia battle for marrow microenvironment
... microscopy tools, they developed systems to monitor the movements of leukemia cells and hematopoietic progenitor cells (HPCs)--a group of cells that includes stem cells as well as more differentiated ... Gene abnormality found to predict childhood leukemia relapse
... in a gene that predict a high likelihood of relapse in children with acute lymphoblastic leukemia (ALL). Although the researchers caution that further research is needed to determine how changes in ... Researchers find way to make tumor cells easier to destroy
... Administration to enter human phase I/II clinical testing in chronic lymphocytic leukemia. In some preliminary studies, GRN163L has been shown to be additive when used in combination with existing ... Researchers find roadmap to next-generation cancer therapies
... cancer therapy – such as the drug Gleevec that works for patients with certain types of leukemia and gastrointestinal tumors – is based on a keen understanding of the architecture of cancer. Much has ... Combination of 2 novel anti-cancer agents may help fight CML resistant to current therapy
... the bone marrow caused by a specific genetic abnormality and is one of the more common forms of leukemia. Imatinib mesylate, or Gleevec, is a highly effective anti-cancer agent that has revolutionized ...
Want to learn more? Search for leukemia group
Return to e! Science News homepage for the latest science news
Molecular change may reveal risk of leukemia relapse
... effective therapy, and lead to new targeted therapies for leukemia,” says study leader Dr. Clara D. ... through a clinical trial sponsored by the Cancer and Leukemia Group B (CALGB), a national clinical ...Gene mutation improves leukemia drug's effect
... to high doses of a particular anticancer drug. The findings, from a Cancer and Leukemia Group B clinical cooperative group study led by Dr. Clara D. Bloomfield, an internationally known AML ...Microenvironment a main driver of aggressive multi-lineage leukemia disease type
... particularly aggressive group of blood cancers known as mixed lineage leukemias (MLL) and how the disease ... early biological processes where human leukemia stem cells can be altered to form a particular ...Not the protein, but its location in the cell, determines the onset of leukemia
... white blood cells in our body combat foreign intruders, such as viruses and bacteria. However, in leukemia, the formation of white blood cells is disturbed: the cells that should develop into white ...Lab study shows methadone breaks resistance in untreatable forms of leukemia
... after methadone treatment. To their surprise, they found that methadone also effectively killed leukemia that was resistant to multiple chemotherapies and to radiation. Probing the mechanism of ...Why Gene Therapy Caused Leukemia In Some 'Boy In The Bubble Syndrome' Patients
... disorder in which the patient lacks most types of immune cell. Almost 10 years ago, two independent groups used gene therapy to treat a few infants with the most common form of SCID, SCID-X1, which is ...Mouse model highlights histone methylation as distinguishing feature for leukemia subtypes
... a new mouse model has led to the identification of a potential therapeutic target for a type of leukemia commonly associated with an unfavorable prognosis. The study, published by Cell Press in the ...UCSD researchers identify potential new drug target for chronic leukemia
... discovered what could be a novel drug target for an often difficult-to-treat form of leukemia. The investigators have identified a unique "signature" or pattern of a specific family of enzymes in ...Interactive gene 'networks' may predict if leukemia is aggressive or slow-growing
... Moores UCSD Cancer Center have evidence that groups, or networks, of interactive genes may be more reliable in determining the likelihood that a form of leukemia is fast-moving or slow-growing. One ...Interactive Gene 'Networks' May Predict If Leukemia Is Aggressive Or Slow-growing
... genes or proteins, researchers have evidence that groups, or networks, of interactive genes may be more reliable in determining the likelihood that a form of leukemia is fast-moving or slow-growing.Stem cells and leukemia battle for marrow microenvironment
... microscopy tools, they developed systems to monitor the movements of leukemia cells and hematopoietic progenitor cells (HPCs)--a group of cells that includes stem cells as well as more differentiated ...Gene abnormality found to predict childhood leukemia relapse
... in a gene that predict a high likelihood of relapse in children with acute lymphoblastic leukemia (ALL). Although the researchers caution that further research is needed to determine how changes in ...Researchers find way to make tumor cells easier to destroy
... Administration to enter human phase I/II clinical testing in chronic lymphocytic leukemia. In some preliminary studies, GRN163L has been shown to be additive when used in combination with existing ...Researchers find roadmap to next-generation cancer therapies
... cancer therapy – such as the drug Gleevec that works for patients with certain types of leukemia and gastrointestinal tumors – is based on a keen understanding of the architecture of cancer. Much has ...Combination of 2 novel anti-cancer agents may help fight CML resistant to current therapy
... the bone marrow caused by a specific genetic abnormality and is one of the more common forms of leukemia. Imatinib mesylate, or Gleevec, is a highly effective anti-cancer agent that has revolutionized ...